TITO R MENDOZA to Cross-Sectional Studies
This is a "connection" page, showing publications TITO R MENDOZA has written about Cross-Sectional Studies.
Connection Strength
0.459
-
Psychometric Validation of the M. D. Anderson Symptom Inventory-Head and Neck Module in the Spanish Language. J Pain Symptom Manage. 2016 06; 51(6):1055-61.
Score: 0.069
-
Measuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment Scale. J Pain. 2015 Oct; 16(10):1032-43.
Score: 0.066
-
Assessment of fatigue in cancer patients and community dwellers: validation study of the Filipino version of the brief fatigue inventory. Oncology. 2010; 79(1-2):112-7.
Score: 0.048
-
Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapy. Br J Haematol. 2023 05; 201(4):738-746.
Score: 0.028
-
Patient-Reported Symptom and Functioning Status during the First 12 Months after Chimeric Antigen Receptor T Cell Therapy for Hematologic Malignancies. Transplant Cell Ther. 2021 11; 27(11):930.e1-930.e10.
Score: 0.025
-
Shared Decision-Making for Lung Cancer Screening: How Well Are We "Sharing"? Chest. 2021 07; 160(1):330-340.
Score: 0.024
-
Validation study of the Japanese version of MD Anderson Symptom Inventory for Brain Tumor module. Jpn J Clin Oncol. 2020 Jul 09; 50(7):787-793.
Score: 0.023
-
The prevalence of altered body image in patients with primary brain tumors: an understudied population. J Neurooncol. 2020 Apr; 147(2):397-404.
Score: 0.023
-
Validation study of the Arabic version of the Brief Fatigue Inventory (BFI-A). East Mediterr Health J. 2019 Nov 25; 25(11):784-790.
Score: 0.022
-
Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients =65?years old. Radiat Oncol. 2017 Sep 09; 12(1):150.
Score: 0.019
-
Validity and Reliability of the Indonesian Version of the Brief Fatigue Inventory in Cancer Patients. J Pain Symptom Manage. 2016 11; 52(5):744-751.
Score: 0.018
-
Racial/ethnic disparities in inflammatory gene single-nucleotide polymorphisms as predictors of a high risk for symptom burden in patients with multiple myeloma 1 year after diagnosis. Cancer. 2015 Apr 01; 121(7):1138-46.
Score: 0.016
-
Impact of cancer-related symptom synergisms on health-related quality of life and performance status. J Pain Symptom Manage. 2008 Jun; 35(6):604-16.
Score: 0.010
-
Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module. Head Neck. 2007 Oct; 29(10):923-31.
Score: 0.010
-
An urban community's preferences for hypothetical outcomes of analgesic pain treatment. J Pain Symptom Manage. 2006 Nov; 32(5):470-7.
Score: 0.009
-
Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer. J Pain Symptom Manage. 2006 Aug; 32(2):118-28.
Score: 0.009
-
Validation of the Taiwanese version of the Brief Fatigue Inventory. J Pain Symptom Manage. 2006 Jul; 32(1):52-9.
Score: 0.009
-
The cancer pain experience of Israeli and American patients 65 years and older. J Pain Symptom Manage. 2005 Sep; 30(3):254-63.
Score: 0.008
-
The cancer pain experience of Israeli adults 65 years and older: the influence of pain interference, symptom severity, and knowledge and attitudes on pain and pain control. Support Care Cancer. 2005 Sep; 13(9):708-14.
Score: 0.008
-
Chinese version of the M. D. Anderson Symptom Inventory: validation and application of symptom measurement in cancer patients. Cancer. 2004 Oct 15; 101(8):1890-901.
Score: 0.008
-
Validation study of the Chinese version of the Brief Fatigue Inventory (BFI-C). J Pain Symptom Manage. 2004 Apr; 27(4):322-32.
Score: 0.008